Lamivudine and Extrasystoles - a phase IV clinical study of FDA data

Summary:

Extrasystoles is reported as a side effect among people who take Lamivudine (lamivudine; zidovudine; nevirapine), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Kaletra,.

The phase IV clinical study analyzes which people have Extrasystoles when taking Lamivudine. It is created by eHealthMe based on reports of 17,197 people who have side effects when taking Lamivudine from the FDA, and is updated regularly.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,242 Lamivudine users. Check the latest studies of Lamivudine.

What is Extrasystoles?

Extrasystoles is found to be associated with 751 drugs and 951 conditions by eHealthMe. Check the latest studies of Extrasystoles.

On Apr, 27, 2026

17,197 people reported to have side effects when taking Lamivudine.
Among them, 16 people (0.09%) have Extrasystoles.

Among these 16 people:

How long have people been on Lamivudine when they have Extrasystoles? *

What is the gender of people who have Extrasystoles when taking Lamivudine? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Extrasystoles when taking Lamivudine? *

What are other drugs people take besides Lamivudine? *

What are other side effects people have besides Extrasystoles? *

Ventricular Extrasystoles (premature cardiac contraction): 15 people, 93.75%
Bradycardia (abnormally slow heart action): 12 people, 75.00%
Diarrhea: 10 people, 62.50%
Arrhythmias (irregular heartbeat): 10 people, 62.50%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 7 people, 43.75%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 37.50%
Chest Pain: 6 people, 37.50%
Nausea And Vomiting: 6 people, 37.50%
Headache (pain in head): 6 people, 37.50%
Supraventricular Extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle): 6 people, 37.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lamivudine and have Extrasystoles?

- Check whether Extrasystoles is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamivudine:

Lamivudine (17,242 reports)

Extrasystoles treatments and more:

Extrasystoles (8,909 reports)

How severe was Extrasystoles and when was it recovered:

Extrasystoles in Lamivudine

Expand to all the drugs that have ingredients of lamivudine; zidovudine; nevirapine:

Extrasystoles and drugs with ingredients of lamivudine; zidovudine; nevirapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamivudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Extrasystoles:

Extrasystoles (751 drugs)

Browse all the conditions that are associated with Extrasystoles:

Extrasystoles (951 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine; nevirapine (the active ingredients of Lamivudine) and Lamivudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.